Futura Medical (LON:FUM) Stock Price Down 5.7% – Should You Sell?

Futura Medical plc (LON:FUM)’s stock price fell 5.7% during mid-day trading on Tuesday . The company traded as low as GBX 0.63 and last traded at GBX 0.63. 1,970,943 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 6,253,206 shares. The stock had previously closed at GBX 0.67.

Futura Medical Price Performance

The stock has a market capitalization of £4.07 million, a price-to-earnings ratio of -0.25 and a beta of 0.01. The firm’s fifty day moving average is GBX 1 and its 200-day moving average is GBX 1.17.

Futura Medical (LON:FUM) last announced its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. The company had revenue of GBX 170 million for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. On average, sell-side analysts expect that Futura Medical plc will post 2.8486672 EPS for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.